The sales revenue of the BioTechUSA company group increased by 40 percent last year
The BioTechUSA company group closed the year 2022 with a record financial result, its sales revenue increased by 41 percent and reached HUF 80.4 billion, its earnings before interest, taxes and depreciation (EBITDA) increased from HUF 9.2 billion to HUF 11.5 billion.
The Hungarian family-owned group of companies expanded its portfolio with 300 new products, opened 17 new stores and launched the largest investment in its history in 2022, which will continue this year – explained Bálint Lévai, CEO and co-owner of BioTechUSA Kft., at the press conference presenting the company’s annual results.
About 80 percent of the total sales revenue of one of the largest food supplement and specialty food manufacturing and distribution groups in Europe last year came from exports, and the international store network produced a 216 percent increase in turnover.
Related news
The BioTechUSA group of companies welcomes applications from domestic healthcare institutions
Three categories, audience prize, HUF 18 million in total prize…
Read more >
Sales of cereals increased the most
Among the 24 commodity groups of agricultural and food industry…
Read more >
BioTechUSA lures you back to the gym with an integrated PR campaign complemented by an unusual charitable initiative
The month of September is one of the most important…
Read more >Related news
Why are parcel locker providers getting stuck? This data points to the reasons
Parcel terminals are becoming increasingly popular: this year, nearly three-quarters…
Read more >
Using 30% less materials would be a solution to the climate crisis
The circular economy is a global imperative: it transcends geographical…
Read more >
Sustainability and health: the rise of plant-based dairy products in Hungary
In recent years, plant-based dairy alternatives have gained significant popularity…
Read more >
